Mathias H.
- Country
- Germany
- Department
- Innere Medizin III
Research Overview
- Phase I Study of IMA401 TCER® in Patients with Solid Tumors: Monotherapy and Combination with Checkpoint Inhibitor
- International Euro Ewing (iEuroEwing) trial for treatment optimisation in patients with Ewing sarcoma
- A Randomized, Open-label, Phase 3 Study of Acalabrutinib in Combination with Rituximab and Reduced Dose CHOP (R-miniCHOP) in Older Adults with Untreated Diffuse Large B-Cell Lymphoma (ARCHED/GLA 2022-1)
Data & Insights
Has run more than one trial at 491 of 808 partner sites.
Specializations
Multiple Myeloma Research
The investigator specializes in the treatment of multiple myeloma, with extensive work in both newly diagnosed and relapsed/refractory cases. Their research encompasses novel therapeutic combinations including elranatamab, daratumumab, and lenalidomide.
- First-line therapy optimization
- Post-transplant maintenance strategies
- Novel drug combinations
Lymphoma Studies
The investigator conducts research in various types of lymphomas, including diffuse large B-cell lymphoma, follicular lymphoma, and Hodgkin lymphoma. Their work focuses on innovative treatment approaches using targeted therapies.
- B-cell lymphoma treatments
- CNS lymphoma management
- Immunotherapy applications
Leukemia Treatment
The investigator studies various forms of leukemia, particularly acute myeloid leukemia and chronic lymphocytic leukemia. Their research includes work with venetoclax combinations and novel therapeutic approaches.
- Treatment-resistant disease
- Targeted therapy development
- Stem cell transplantation
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.